Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px
Document › Details

Toshiba Corporation. (3/27/14). "Press Release: Toshiba to Reinforce Healthcare Systems & Services Businesses". Tokyo.

Organisations Organisation Toshiba Corporation, Healthcare Business Development Division
  Group Toshiba (Group)
  Organisation 2 Toshiba Medical Systems Corporation (TMSC)
  Group Toshiba (Group)
Products Product diagnostic device
  Product 2 medical device

Toshiba Corporation (Tokyo: 6502) today announced that it will promote acceleration and expansion of its healthcare business by consolidating Toshiba Group's healthcare-related businesses in a new in-house company, the Healthcare Company, that will be established on July 1. As the global population continues to rise and the developed economies continue to see the graying of society, the healthcare market is expected to enjoy continuous growth in coming years. The Healthcare Company will position Toshiba to grow with the market.

The new company will integrate a wide array of know-how and technologies and deploy them to promote business in following key areas: Diagnosis & Treatment, which will explore new generations of diagnostic imaging in addition to current systems; Prevention, which will aim to reduce the risk of disease; and Convalescence & Nursing Care, which will aid people in recovering from disease and injury. On its establishment, the new in-house company will be around 9,000 people scale.

The Healthcare Company will absorb Toshiba's current Healthcare Business Development Division, the carbon iron radiotherapy system currently handled by the Power Systems Company, the Materials & Devices Division's DNA analysis system, and other healthcare businesses from across Toshiba Group.

Toshiba Medical Systems Corporation (TMSC), which develops and markets diagnostic imaging systems, including computed tomography and magnetic resonance imaging systems, and medical IT systems, will be positioned as a subsidiary of the Healthcare Company. With global experience spanning more than 135 countries, TMSC will contribute a strong customer base and business assets that will support the new company in integrating and aligning its business operations.

In July 2013, Toshiba defined Healthcare as third major pillar of business, alongside Energy and Storage, and in February 2014 the company announced its strategies for the healthcare business and a fiscal year 2015 sales target of 600 billion yen (approx. UD$6 billion). In keeping with this commitment, Toshiba has now decided to unify all of its healthcare businesses into the new in-house company. By promoting "New Concept Innovation," the Healthcare Company will bring together the wide-ranging technologies of Toshiba Group to create unique, innovative products and services, and to reinforce and expand its business via diverse sales channels.


Information in the press releases, including product prices and specifications, content of services and contact information, is current on the date of the press announcement, but is subject to change without prior notice.

Record changed: 2019-06-09


Picture [iito] No Tracking 650x80px

More documents for Toshiba (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture [iito] Männer Ballett 650x80px

» top